Insider · CIK 0002008384
Brian Cogley
Files at ZSQR (Coeptis Therapeutics Holdings, Inc.). First filing Jan 17, 2024, latest Jan 17, 2024.
In brief
Brian Cogley files SEC Form 4 as CFO at ZSQR (Coeptis Therapeutics Holdings, Inc.). Since Jan 17, 2024, Brian Cogley has reported 1 open-market buy worth $3,350 and 0 open-market sells worth $0, the latest filed on Jan 17, 2024.
A track record needs three past buys with six months of prices behind them; Brian Cogley has 0, so none is measured yet.
The newest scored trade: bought $3,350 of ZSQR on Jan 10, 2024, filed Jan 17, 2024, scored 61 (notable).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
ZSQR: Coeptis Therapeutics Holdings, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 61Notable | Coeptis Therapeutics Holdings, Inc. | $3,350 5,000 shares | +20% | +7% from low-68% from high |
Transactions
Every row this insider has filed, 8 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 27, 2026 | ZSQR Coeptis Therapeutics Holdings, Inc. | MOption exercise Common Stock | +4,112 | $0.00 | $0 | 26,612 | 11 d ago |
| Jul 27, 2026 | ZSQR Coeptis Therapeutics Holdings, Inc. | MOption exercise Restricted Stock Unitsderivative | -4,112 | $0.00 | $0 | 12,335 | 11 d ago |
| Apr 27, 2026 | ZSQR Coeptis Therapeutics Holdings, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +100,000 | $0.00 | $0 | 100,000 | Apr 30, 2026 |
| Apr 27, 2026 | ZSQR Coeptis Therapeutics Holdings, Inc. | AGrant or award Restricted Stock Unitsderivative | +16,447 | $0.00 | $0 | 16,447 | Apr 30, 2026 |
| Feb 11, 2026 | ZSQR Coeptis Therapeutics Holdings, Inc. | MOption exercise Common stock | +10,000 | $10.56 | $106k | 22,500 | Feb 13, 2026 |
| Feb 11, 2026 | ZSQR Coeptis Therapeutics Holdings, Inc. | AGrant or award Common Stock | +12,500 | $0.00 | $0 | 22,500 | Feb 13, 2026 |
| Mar 4, 2025 | ZSQR Coeptis Therapeutics Holdings, Inc. | AGrant or award Non-Qualified Stock Options (right to buy)derivative | +10,000 | - | - | 22,500 | Mar 6, 2025 |
| Jan 10, 2024 | ZSQR Coeptis Therapeutics Holdings, Inc. | POpen-market purchase Common Stock | +5,000 | $0.67 | $3,350 | 30,000 | Jan 17, 2024 |
Questions about Brian Cogley
Answered from the filings on this page, as of the latest one.
Is Brian Cogley buying or selling?
Not in the last 12 months. Brian Cogley's latest open-market trade on SEC Form 4 was bought $3,350 of ZSQR on Jan 10, 2024.
How did Brian Cogley's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Brian Cogley has 0.
Where does Brian Cogley file Form 4?
Brian Cogley has filed Form 4 at ZSQR (Coeptis Therapeutics Holdings, Inc.) as Chief Financial Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.